| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration.
|
J Biol Chem
|
2002
|
2.28
|
|
2
|
A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha.
|
Hepatology
|
2005
|
2.18
|
|
3
|
The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy.
|
Diabetes
|
2006
|
1.80
|
|
4
|
Identification of acyl coenzyme A:monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorption.
|
J Biol Chem
|
2003
|
1.57
|
|
5
|
Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.
|
Circ Cardiovasc Imaging
|
2010
|
1.57
|
|
6
|
Anti-inflammatory therapeutics for the treatment of atherosclerosis.
|
Nat Rev Drug Discov
|
2011
|
1.48
|
|
7
|
Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations.
|
Diabetes
|
2009
|
1.23
|
|
8
|
Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration.
|
Hepatology
|
2002
|
1.23
|
|
9
|
Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity.
|
Mol Cancer Ther
|
2005
|
1.20
|
|
10
|
From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.
|
Diabetes
|
2006
|
1.20
|
|
11
|
Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation.
|
Mol Cell Biol
|
2003
|
1.16
|
|
12
|
Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice.
|
J Clin Invest
|
2003
|
1.13
|
|
13
|
Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
|
J Biol Chem
|
2005
|
1.11
|
|
14
|
Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats.
|
Mol Pharmacol
|
2004
|
1.06
|
|
15
|
Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
|
J Biol Chem
|
2002
|
1.04
|
|
16
|
Iyengar yoga for young adults with rheumatoid arthritis: results from a mixed-methods pilot study.
|
J Pain Symptom Manage
|
2010
|
1.00
|
|
17
|
Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescence.
|
Biochem J
|
2008
|
0.97
|
|
18
|
Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvant.
|
Clin Vaccine Immunol
|
2008
|
0.95
|
|
19
|
A glucose sensor role for glucokinase in anterior pituitary cells.
|
Diabetes
|
2006
|
0.93
|
|
20
|
Receptor occupancy of nonpeptide corticotropin-releasing factor 1 antagonist DMP696: correlation with drug exposure and anxiolytic efficacy.
|
J Pharmacol Exp Ther
|
2003
|
0.88
|
|
21
|
Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.
|
J Med Chem
|
2011
|
0.83
|
|
22
|
Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodents.
|
Eur J Pharmacol
|
2005
|
0.82
|
|
23
|
Sociodemographic factors in a pediatric chronic pain clinic: The roles of age, sex and minority status in pain and health characteristics.
|
J Pain Manag
|
2010
|
0.82
|
|
24
|
Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia.
|
J Med Chem
|
2014
|
0.76
|
|
25
|
Adenovirus-mediated overexpression of activin beta(C) subunit accelerates liver regeneration in partially hepatectomized rats.
|
J Hepatol
|
2005
|
0.75
|
|
26
|
Potent, selective MCH-1 receptor antagonists.
|
Bioorg Med Chem Lett
|
2008
|
0.75
|
|
27
|
Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors.
|
Bioorg Med Chem Lett
|
2011
|
0.75
|